Clinical Trials Browser

Phase 1/2 × INDUSTRY × ofatumumab × Clear all

NCT01217749 2015-06-25

PCYC-1109-CA

Phase 1/2 Completed

71 enrolled 10 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT00092274 2015-04-21

Study of HuMax-CD20, a New Drug to Treat Early Stage Non-Hodgkin´s Follicular Lymphoma

Phase 1/2 Withdrawn

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

NCT00093314 2015-04-21

HuMax-CD20 in Chronic Lymphocytic Leukemia

Phase 1/2 Withdrawn

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell